Source:http://linkedlifedata.com/resource/pubmed/id/21622562
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
30
|
pubmed:dateCreated |
2011-7-25
|
pubmed:abstractText |
Protection against infection with Mycobacterium tuberculosis demands IFN-?. SOCS1 has been shown to inhibit responses to IFN-? and might thereby play a central role in the outcome of infection. We found that M. tuberculosis is a highly efficient stimulator of SOCS1 expression in murine and human macrophages and in tissues from infected mice. Surprisingly, SOCS1 reduced responses to IL-12, resulting in an impaired IFN-? secretion by macrophages that in turn accounted for a deteriorated intracellular mycobacterial control. Despite SOCS1 expression, mycobacteria-infected macrophages responded to exogenously added IFN-?. SOCS1 attenuated the expression of the majority of genes modulated by M. tuberculosis infection of macrophages. Using a conditional knockdown strategy in mice, we found that SOCS1 expression by macrophages hampered M. tuberculosis clearance early after infection in vivo in an IFN-?-dependent manner. On the other hand, at later time points, SOCS1 expression by non-macrophage cells protected the host from infection-induced detrimental inflammation.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical |
http://linkedlifedata.com/resource/pubmed/chemical/Interferon-gamma,
http://linkedlifedata.com/resource/pubmed/chemical/Interleukin-12,
http://linkedlifedata.com/resource/pubmed/chemical/SOCS1 protein, human,
http://linkedlifedata.com/resource/pubmed/chemical/Socs1 protein, mouse,
http://linkedlifedata.com/resource/pubmed/chemical/Suppressor of Cytokine Signaling...
|
pubmed:status |
MEDLINE
|
pubmed:month |
Jul
|
pubmed:issn |
1083-351X
|
pubmed:author |
pubmed-author:BhujuSabinS,
pubmed-author:CarowBeritB,
pubmed-author:Gavier-WidénDoloresD,
pubmed-author:IgnatowiczLechL,
pubmed-author:OehlmannWulfW,
pubmed-author:RottenbergMartin EME,
pubmed-author:SinghMahavirM,
pubmed-author:SköldMarkusM,
pubmed-author:WigzellHansH,
pubmed-author:YeXiang qunX,
pubmed-author:YoshimuraAkihikoA
|
pubmed:issnType |
Electronic
|
pubmed:day |
29
|
pubmed:volume |
286
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
26873-87
|
pubmed:meshHeading |
pubmed-meshheading:21622562-Animals,
pubmed-meshheading:21622562-Gene Expression Regulation,
pubmed-meshheading:21622562-Gene Silencing,
pubmed-meshheading:21622562-Humans,
pubmed-meshheading:21622562-Interferon-gamma,
pubmed-meshheading:21622562-Interleukin-12,
pubmed-meshheading:21622562-Macrophages,
pubmed-meshheading:21622562-Mice,
pubmed-meshheading:21622562-Mice, Knockout,
pubmed-meshheading:21622562-Mice, Mutant Strains,
pubmed-meshheading:21622562-Mycobacterium tuberculosis,
pubmed-meshheading:21622562-Suppressor of Cytokine Signaling Proteins,
pubmed-meshheading:21622562-Tuberculosis
|
pubmed:year |
2011
|
pubmed:articleTitle |
Silencing suppressor of cytokine signaling-1 (SOCS1) in macrophages improves Mycobacterium tuberculosis control in an interferon-gamma (IFN-gamma)-dependent manner.
|
pubmed:affiliation |
Department of Microbiology, Tumor and Cell Biology, Karolinska Institutet, Stockholm 17177, Sweden.
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|